TW224940B - - Google Patents

Info

Publication number
TW224940B
TW224940B TW080106176A TW80106176A TW224940B TW 224940 B TW224940 B TW 224940B TW 080106176 A TW080106176 A TW 080106176A TW 80106176 A TW80106176 A TW 80106176A TW 224940 B TW224940 B TW 224940B
Authority
TW
Taiwan
Application number
TW080106176A
Other languages
Chinese (zh)
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority claimed from PCT/SE1991/000522 external-priority patent/WO1992003134A1/en
Application granted granted Critical
Publication of TW224940B publication Critical patent/TW224940B/zh

Links

TW080106176A 1991-08-07 1991-08-06 TW224940B (cs)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/SE1991/000522 WO1992003134A1 (en) 1990-08-15 1991-08-07 New pharmaceutical formulations of 5-(2-chloro-1-hydroxyethyl)-4-methylthiazole

Publications (1)

Publication Number Publication Date
TW224940B true TW224940B (cs) 1994-06-11

Family

ID=51454275

Family Applications (1)

Application Number Title Priority Date Filing Date
TW080106176A TW224940B (cs) 1991-08-07 1991-08-06

Country Status (1)

Country Link
TW (1) TW224940B (cs)

Similar Documents

Publication Publication Date Title
DK0608366T3 (cs)
DK0526024T3 (cs)
CH0502314H1 (cs)
DE4291719T1 (cs)
EP0497366A3 (cs)
DE4290891T1 (cs)
EP0502544A3 (cs)
DE4290924T1 (cs)
DK0539725T3 (cs)
DK0520894T3 (cs)
DE4290741T1 (cs)
DE4291109T1 (cs)
DE4290190T1 (cs)
DK0516009T3 (cs)
ATA37391A (cs)
DE4193594T1 (cs)
ECSM91528U (cs)
AU8357291A (cs)
ECSM91558U (cs)
AU7627691A (cs)
AU7382991A (cs)
CN3009792S (cs)
CN3009796S (cs)
CN3010205S (cs)
CN3009741S (cs)